In 1945, he returned to the NIMR, and worked with
John Cornforth on a commercially attractive way of synthesising
cortisone from naturally occurring steroids. (
Merck & Co had a long and complex synthesis from bile acids, the only known source of cortisone in quantity.) One possible source was sarmentogenin, found in extracts of arrow poisons (heart poisons) from
Strophanthus seeds, but there was confusion about which species. During the course of this work Callow went to Nigeria at the invitation of
Ibadan University, for six months with
R.D. Meikle, a botanist from the
Royal Botanic Gardens, Kew, to collect arrow poison material.
S. sarmentosus was found to contain sarmentogenin but it was not easy to cultivate or to produce in sufficiently large quantities. Another possible source was hecogenin from
Agave sisalana, a plant native to Mexico, grown commercially in Kenya. This was a less direct way of producing cortisone, but the successful extraction and purification of hecogenin from the
sisal plant, and its availability made it a suitable commercial source.
Glaxo Laboratories cooperated with Cornforth and Callow to devise a production process for cortisone from hecogenin. In this case the work done by NIMR staff was patented and sold to Glaxo Labs. Callow was elected as a Fellow of the Royal Society (FRS) in 1958. ==Honeybee pheromones==